GLP-1 therapy is evolving rapidly, and the newest retatrutide Phase 3 data shows just how far obesity medicine has come
It's not yet clear how fibers achieve this, but the authors of the review suspect that they increase the release of gut hormones, like GLP-1, thereby stimulating insulin and suppressing appetite
For example, in a sample of patients with established schizophrenia, Iwata et al
Your provider can help navigate insurance approval processes
This results in enhanced muscle growth, better fat loss, and improvements in overall body composition and hormone levels
All these medications are meant to be used alongside lifestyle modifications, which remain the bedrock for treating obesity, stresses Dr